Tesla’s FSD Price Cuts Could Boost Shares, Says RBC Analystby Mark Eisenberg 08.08.2024RBC analysts believe that reducing Tesla's FSD subscription price could drive stock performance, despite recent challenges.
Mosaic Co. Outlook Brightens Amid Cost Management and Market Demandby Mark Eisenberg 08.08.2024Mosaic Co. forecasts growth due to strong demand in phosphate and potash markets, despite a decline in EPS and revenue.
Robinhood’s Earnings Soar Thanks to Cryptocurrency Tradingby John Darbie 08.08.2024Robinhood's Q2 earnings soar with a 161% surge in cryptocurrency trading. Discover the key factors behind this financial milestone.
Hecla Mining Reports Record Revenues and High Silver Productionby Mark Eisenberg 08.08.2024Hecla Mining sees record revenues and near-historic silver production in Q2 2024, focusing on cash flow, investments, and debt reduction.
Bridge Investment Group Reports Q2 2024: Mixed Financial Resultsby Mark Eisenberg 08.08.2024Bridge Investment Group shows mixed results in Q2 2024 with a GAAP net loss but strong distributable earnings and strategic ...
OppFi Shines with Record Q2 Earnings and Increased Guidanceby Mark Eisenberg 08.08.2024OppFi Inc. surpasses expectations with record Q2 results, increases full-year earnings guidance by 20%, and invests strategically in Bitty Advance.
Astec Industries Achieves $345.5M Net Sales Amid Infrastructure Boomby Mark Eisenberg 08.08.2024Astec Industries reports strong Q2 performance with net sales of $345.5M, driven by high demand in Infrastructure Solutions segment.
HubSpot Stock Soars 7% on Earnings Beat and Strong FY Guidanceby Mark Eisenberg 08.08.2024HubSpot shares surged 7% after robust Q2 earnings, beating estimates, and raising its full-year guidance, reaffirming growth momentum.
Elon Musk’s Bold Vision for X: Dogecoin Set to Skyrocket?by John Darbie 08.08.2024Elon Musk's plan for X as an everything app advances with new payment features. Could this launch skyrocket Dogecoin's value?
CVS Health Updates EPS Guidance and Operational Plansby Mark Eisenberg 08.08.2024CVS Health revises full-year EPS guidance to $6.40-$6.55 and plans significant operational improvements to drive future growth.